Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Golden State Equity Partners boosted its position in Lamar Advertising (NASDAQ:LAMR – Free Report) by 17.4% in the fourth quarter, according to its most recent disclosure with the Securities and ...

In a report released today, William Katz from TD Cowen maintained a Buy rating on KKR & Co (KKR – Research Report), with a price target of ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

TD Cowen analysts increased the price target for Synchrony Financial (NYSE:SYF) shares to $80.00, up from the previous $75.00, while reiterating a Buy rating. The adjustment follows Synchrony ...

TD Cowen's model also assumes that capital expenditures ... For detailed analysis of DKS's financial health and growth prospects, including comprehensive valuation models and peer comparisons ...

For detailed analysis of DKS's financial health and growth prospects, including comprehensive valuation models and peer comparisons, explore the full research report available on InvestingPro. TD ...

Insurance broker Willis Towers Watson beat Wall Street estimates for fourth-quarter profit on Tuesday, driven by a strong ...

The TD Cowen analyst's comments underscore the challenges the company faces in achieving its financial targets. Investors are advised to monitor DarioHealth's performance closely, especially regarding ...

Cowan-Dickie, a renowned gamer who at one stage was ranked world No 1 for Call of Duty, gave it up to focus on his recovery and ditched the alcohol, too. Yet the biggest challenge still lay ahead.